Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Test Kit Detects Melamine In Infant Formula And Other Food
Larry Wackett and Michael Sadowsky, members of the University of Minnesota"s BioTechnology Institute, developed an enzyme that is used in Bioo Scientific"s new MaxDiscovery™ Melamine Test kit, which simplifies the detection of melamine contamination in food. Melamine is an industrial chemical that killed six Chinese children and hospitalized 150,000 last year after it was added to milk to increase its apparent protein content. Some children may have life-long chronic kidney problems resulting from melamine exposure.
generic viagra online
AstraZeneca Studies Show Relief Of Nighttime Heartburn And Reduction In GERD-Related Sleep Disturbances
Two studies from AstraZeneca (NYSE: AZN) show that symptomatic gastroesophageal reflux disease (GERD) patients treated with NEXIUM(R) (esomeprazole magnesium) 20 mg daily experienced greater relief from nighttime heartburn and GERD-related sleep disturbances compared with patients taking placebo over four weeks(1). NEXIUM 20 mg is indicated for the treatment of heartburn and other symptoms associated with GERD. NEXIUM, in a class of drugs called proton pump inhibitors (PPIs), demonstrated efficacy in relieving moderate-to-severe nighttime heartburn and GERD-related sleep disturbances in two randomized, placebo-controlled trials(2). These findings were presented in three separate abstracts at Digestive Disease Week 2009 in Chicago.
News of the day
Altus Pharmaceuticals Reports Dosing First Patient In A Phase 2 Trial Of ALTU-238 For Pediatric Growth Hormone Deficiency
Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced that patient dosing in its Phase 2 trial for ALTU-238 in growth hormone deficiency pediatric subjects began on June 2, 2009. ALTU-238 is a long-acting, extended-release formulation of recombinant human growth hormone (rhGH, somatropin), which is being developed utilizing Altus" proprietary protein crystallization technology. ALTU-238 is a ready-to-use liquid suspension of crystallized rhGH that preserves the structure of the rhGH molecule without the need for pegylation, polymerization, or encapsulation and enables administration through a fine gauge needle. The Phase 2 ALTU-238 pediatric trial is being conducted in approximately 18 clinical sites in the U.S. and targets enrolling 36 growth hormone deficient pediatric patients. ALTU-238 has been studied in a series of Phase 1 and Phase 2 studies in healthy and GH deficiency adults.
Diagnostics

Healtier Future For All Australians Report Welcomed

The release of the National Health and Hospitals Reform Commission report, A Healthier Future for All Australians, has been welcomed by the Pharmaceutical Society of Australia as a major step in laying the foundations for improved health care in Australia. Vice-President of the PSA, Shane Jackson, said the report specifically highlighted the need for increased emphasis on preventive health, a message that is strongly supported by the PSA. "At present only about 2 per cent of the health-care budget is devoted to preventive health and this is an area PSA has been advocating that needs to be addressed as a priority in reforming the health-care system," Dr Jackson said. "The PSA has in place the Pharmacy Self Care program which is a model for the successful implementation of preventive health programs that are both effective and can provide long-term cost savings to the Government. "The infrastructure is already in place and PSA welcomes the opportunity to consult with the Government to ensure its preventive heath focus is efficient and effective." Dr Jackson said the report also highlighted the need for a more holistic and patient-focussed approach to health care in Australia. "The report emphasised the need for greater development of the multidisciplinary health-care team and the PSA stresses that pharmacists are pivotal to such an approach because of their skills and the fact they are the most accessible health-care professionals," Dr Jackson said. "The Government must consider expanding the role of pharmacists to ensure the effectiveness and success of multidisciplinary health-care teams. "The Healthier Future for All Australians report further develops this concept. PSA awaits the impending release of the reports into primary health and preventive health in the near future which will provide the opportunity for an integrated and focussed approach to be directed towards health-care reform. "One area which need to be examined, and has been touched on in the Healthier Future report, is the immediate development and implementation of an eHealth system. "The report recommends that reforms be implemented by 2012 which are in line with PSA recommendations that the Government bring forward its 10-year plan to reform the national health system. "The PSA will consider the details of the report and respond to the Government in due course." Pharmaceutical Society of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009